Brain neurotoxic amyloid-beta peptides: Their potential role in the pathophysiology of depression and as molecular therapeutic targets

British Journal of Pharmacology

Volumn 161, Issue 4, 2010, Pages 768-770

  Pomara, Nunzio ^a   Sidtis, John J ^b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NONE

Author keywords

amyloid lowering drugs; amyloid ; major depressive disorder; neurotoxicity; pharmacological treatment; treatment resistant depression

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BRAIN MONOAMINE; DOPAMINE; NORADRENALIN; SEROTONIN;

AMYLOIDOSIS; DEPRESSION; NEUROBIOLOGY; NEUROTOXICITY; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 77957245776     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00948.x     Document Type: Note

References (17)

1. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N et al. (2009). The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 14 : 95 105.
2. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48 : 913 922.
3. Colaianna M, Tucci P, Zotti M, Morgese MG, Schiavone S, Govoni S et al. (2010). Soluble beta amyloid (1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol 159 : 1704 1715.
4. Dong H, Csernansky JG (2009). Effects of stress and stress hormones on amyloid-beta protein and plaque deposition. J Alzheimers Dis 18 : 459 469.
5. Filali M, Lalonde R, Rivest S (2009). Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav 8 : 143 148.
6. Gonzalo-Ruiz A, González I, Sanz-Anquela JM (2003). Effects of beta-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat. J Chem Neuroanat 26 : 153 169. (Pubitemid 38112732)
7. Gudmundsson P, Skoog I, Waern M, Blennow K, Pálsson S, Rosengren L et al. (2007). The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am J Geriatr Psychiatry 15 : 832 838.
8. Gudmundsson P, Skoog I, Waern M, Blennow K, Blennow K, Rosengren L et al. (2010). Is there a CSF biomarker profile related to depression in elderly women? Psychiatry Res 176 : 174 178.
9. Insel TR, Wang PS (2009). The STAR*D trial: revealing the need for better treatments. Psychiatr Serv 60 : 1466 1467.
10. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM (2007). Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci U S A 104 : 10673 10678. (Pubitemid 47185723)
11. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326 : 1005 1007.
12. Kita Y, Baba H, Maeshima H, Nakano Y, Suzuki T, Arai H (2009). Serum amyloid protein in young and elderly depression: a pilot study. Psychogeriatrics 9 : 180 185.
13. Kulstad JJ, McMillan PJ, Leverenz JB, Cook DG, Green PS, Peskind ER et al. (2005). Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque. J Neuropathol Exp Neurol 64 : 139 146.
14. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron 3 : 651 660. (Pubitemid 40320700)
15. Pomara N, Sidtis J (2007). Possible therapeutic implication of abeta disturbances in depression. Int J Geriatr Psychiatry 22 : 931 932. (Pubitemid 47455279)
16. Pomara N, Doraiswamy PM, Willoughby LM, Roth AE, Mulsant BH, Sidtis JJ et al. (2006). Elevation in plasma abeta42 in geriatric depression: a pilot study. Neurochem Res 31 : 341 349. (Pubitemid 43829323)
17. Sun X, Mwamburi DM, Bungay K, Prasad J, Yee J, Lin YM et al. (2007). Depression, antidepressants, and plasma amyloid beta peptides in those who do not have cardiovascular disease. Biol Psychiatry 62 : 1413 1417. (Pubitemid 350180722)